Utilizing 18 F-AV-133 VMAT2 PET Imaging to Monitor Progressive Nigrostriatal Degeneration in Parkinson Disease.
Leah C BeauchampVincent DoréVictor L VillemagneSanSan XuDavid FinkelsteinKevin J BarnhamChristopher C RowePublished in: Neurology (2023)
This study provides Class IV evidence that VMAT2 PET can detect patients with Parkinson Disease and quantify progression over a two-year window.